Company Data

Aerovate Therapeutics Inc.

Ticker
AVTE
Current Price
$2.37 -0.84%
Market Cap
$68.4M
Price Target
Refer to Report
Volume
123.0K
52wk Range
$1.25 - $32.415
Advanced Market Data

Overview

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy